Trials / Completed
CompletedNCT04538638
Mesenteric SParIng Versus Central mesenterectomY in Ileocolic Resection for Terminal Ileitis in Crohn's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this multicenter randomised controlled trial is to analyse the six month endoscopic recurrence following a mesenteric sparing versus a central mesenterectomy performing an ileocolic resection for CD.
Detailed description
There is emerging evidence to suggest that Crohn's disease (CD) may be a disease of the mesentery rather than just of the bowel alone. A more extensive central mesenterectomy (up to the level of the ileocolic artery), in order to remove an increased volume of affected mesentery to prevent postoperative CD, has been suggested to lead to beneficial results. It is hypothesised that patients who undergo a central mesenterectomy during an ileocolic resection compared to a mesenteric sparing ileocolic resection will have decreased recurrence rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Mesenteric sparing ileocolic resection | Mesentery left in situ |
| PROCEDURE | Central mesenterectomy ileocolic resection | Mesentery is taken up to the level of the ileocolic trunk |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2023-05-01
- Completion
- 2023-11-27
- First posted
- 2020-09-04
- Last updated
- 2023-12-26
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04538638. Inclusion in this directory is not an endorsement.